The attempted cross examination of former US Chief Medical Adviser Dr Anthony Fauci in Congressional Hearings by Senator Ron Johnson and Rand Paul last week throws a light on why Fauci refused to answer 110 questions about his role in the rollout of the Covid vaccine bioweapon.
In this remarkable interview the indefatigable Dr David Martin exposes the greatest ever malevolent medical attack on humanity with a bioweapon undertaken by government, the military and big pharma. This same offensive was initiated in Australia by the Liberal National Party, supported by Labor when in government in 2020.
Opposition Leader Angus Taylor and his supportive legacy media refuse to acknowledge the damaged populace has a long memory which is why a significant proportion no longer trusts or supports major parties.
Former President Joe Biden’s ‘auto-pen’ issued a preemptive, unconditional federal pardon to Dr. Anthony Fauci in his final hours in office, covering any potential federal crimes or conduct related to COVID-19 between January 1, 2014, and January 19, 2025.
He describes the Congressional Hearing with Dr Fauci as “putting lipstick on a propaganda pig” and a “mock show” resulting in contempt determinations against Fauci for invoking the Fifth Amendment 110 times.
Dr Martin said he personally presented vital medical evidence in 2001 to Senator Ron Johnson and Rand Paul detailing why the experimental rollout of the mRNA gene-altering vaccine should stop.
His vital evidence was ignored. “Rand Paul and Ron Johnson should have stopped the emergency authorisation being promulgated in the first place,” Dr Martin said.
“There were proven methods to treat coronavirus exposure that were published by the very people who made the bioweapon in the first place.
“Now they (Rand Paul and Ron Johnson) are trying to buy back conscience that they sold to the pharmaceutical interests and federally-funded research interests at their state universities and state and federal labs.”
Dr. David Martin is the founding CEO of M∙CAM Inc. M∙CAM is the international leader in intellectual property-based financial risk management. From auditing patent quality for governments and patent offices, to providing state-of-the-art actuarial risk management systems and solutions to the largest banks and insurance companies, M∙CAM has established a global standard in patent quality and commercial validity assessment and management.
A spokesman for global intellectual property accountability and quality reform, Dr. Martin has worked closely with the United States Congress, numerous trade and finance regulatory agencies in the United States, Europe and Asia, in advocating and deploying infrastructure to support growing reliance on proprietary rights in business transactions. M∙CAM has supported the modernization of intellectual property, tax, and accounting laws through its work with oversight agencies and policy makers.
As former Assistant Professor at the University of Virginias School of Medicine, Dr. Martin founded the Universitys first wholly-owned, for-profit, research and development and technology transfer corporation. Engaged in domestic and international technology transfer, clinical research, and financing, this company pioneered new techniques innovation management that have become industry standards. In 1999, Dr. Martin was appointed by the Governor of the Commonwealth of Virginia to serve on the Joint Commission on Technology and Science and has served the General Assembly and Virginias Center for Innovative Technology on numerous occasions.
Dr. Martins work with the Batten Institute at the Darden Graduate School of Business Administration at the University of Virginia and his related work at the Indian Institute for Management in Ahmedabad India has brought unprecedented curricular focus to areas of intangible asset risk management, finance, and accounting standards. In addition to his academic work, Dr. Martin has closely advised intellectual property based finance and investment programs in India, China, Denmark, the European Union, the United Kingdom, South Africa, the Islamic Republic of Iran, the United States, and the United Arab Emirates.
He was the founding Director of Melbourne’s Centre of Applied Innovation when living in Australia.
Dr. Martin has publications in law, medicine, engineering, finance and education. He maintains active research in the fields of linguistic genomics, fractal financial risk modeling, as well as continuing his over 15 years of research in cellular membrane ionic signaling.